Table 1 Baseline characteristics of PLA2R antibody associated MN patients.
From: Nomogram for thromboembolic events in primary membranous nephropathy associated with PLA2R antibody
Variables | Training (N = 969) | Validation (N = 415) |
|---|---|---|
Gender (male/ female) | 640/ 329 | 287/ 128 |
Age (year) | 51(42, 60) | 53 (44, 60) |
PLA2R antibody titer (RU/ml) | 58.9 (17.8, 156.7) | 58.3 (19.6, 121.7) |
Creatinine (µmol/L) | 72 (59, 86) | 75 (61, 92) |
24-h proteinuria (g) | 4.86 (2.71, 7.77) | 5.76 (3.06, 9.07) |
Albumin (g/L) | 23.9 (20.0, 28.6) | 24.0 (20.4, 29.1) |
haemoglobin (g/L) | 131 (118, 143) | 127 (114, 138) |
Platelet (×109/L) | 237 (193, 281) | 242 (198, 289) |
Total cholesterol (mmol/l) | 7.04 (5.65, 8.70) | 6.89 (5.39, 8.54) |
Low-density lipoprotein (mmol/l) | 4.74 (3.46, 6.25) | 4.32 (3.16, 5.73) |
D-Dimer (g/ml) | 0.32 (0.16, 0.75) | 0.51 (0.23, 1.35) |
Fibrinogen (mg/dl) | 4.1 (3.5, 4.8) | 4.2 (3.5, 5.1) |
APTT | 30.1 (27.0, 32.8) | 28.4 (26.4, 30.7) |
PT | 9.7 (9.3, 10.3) | 10.3 (9.8, 10.8) |
